FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称NAVAFENTEROL
异名/同义词LAS191351
LAS-191351
NAVAFENTEROL
NAVAFENTEROL [INN]
NAVAFENTEROL [USAN]
TRANS-4-((3-(5-((((2R)-2-HYDROXY-2-(8-HYDROXY-2-OXO-1,2-DIHYDRO-5- QUINOLINYL)ETHYL)AMINO)METHYL)-1H-BENZOTRIAZOL-1-YL)PROPYL)(METHYL)AMINO)CYCLOHEXYL HYDROXY(DI-2-THIENYL)ACETATE
2-THIOPHENEACETIC ACID, .ALPHA.-HYDROXY-.ALPHA.-2-THIENYL-, TRANS-4-((3-(5-((((2R)-2-(1,2-DIHYDRO-8-HYDROXY-2-OXO-5-QUINOLINYL)-2-HYDROXYETHYL)AMINO)METHYL)-1H-BENZOTRIAZOL-1-YL)PROPYL)METHYLAMINO)CYCLOHEXYL ESTER
AZD 8871 [WHO-DD]
AZD8871
AZD-8871
CAS登记号1435519-06-4
物质唯一标识(Unique Ingredient Identifier)U29GY32XJ4
分子式C38H42N6O6S2
国际化合物标识(International Chemical Identifier,InChI)ZNKWRAKPQQZLNX-ZDQHWEPJSA-N
SMILESc1(cccs1)C(C(=O)O[C@H]2CC[C@@H](CC2)N(C)CCCn3nnc4c3ccc(c4)CNC[C@H](O)c5c6ccc([nH]c6c(cc5)O)=O)(c7cccs7)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System